Besides the renal disorders, our investigation further proposed down-regulated expressions of WT1 and PODXL as desirable indicators for incremental risk (Supplementary Figures 1–4 and Supplementary Tables 1–2) and unfavorable prognosis (i.e., renal survival) of IMN (Figure 3 and Table 3). Here, PODXL is linked to kidney disorder.